Recombinant Human ETF1 Protein，His

The study of ETF1 (Elongation Factor Ts-1) recombinant protein has gained significant attention due to its critical role in various cellular processes, particularly in protein synthesis and cellular stress responses. As a member of the elongation factor family, ETF1 facilitates the binding of aminoacyl-tRNA to ribosomes, thereby influencing the efficiency and accuracy of translation during protein synthesis. Research into ETF1 has highlighted its importance not only in basic cellular biology but also in the context of disease, as alterations in its expression or function can be linked to various pathologies, including cancers and neurodegenerative disorders. Furthermore, the ability to produce ETF1 as a recombinant protein opens avenues for detailed structural and functional analyses, enabling insights into its interactions and mechanisms of action. The recombinant form allows researchers to explore its potential applications in biotechnology and therapeutic developments, including the design of targeted treatments that can modulate protein synthesis in diseased cells. Overall, understanding ETF1 through recombinant protein studies enhances our knowledge of cellular dynamics and holds promise for advancing therapeutic strategies in medicine.